Timo Minssen (Former)
41 – 50 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
How does emerging patent case law in the US and Europe affect precision medicine?
- Contribution to journal › Article
-
Mark
Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part I)
(2019)
- Other contribution › Miscellaneous
- 2018
-
Mark
A Ray of Light in Muddy Waters? -The CJEU rules on combination SPCs in C-121/17 Teva v Gilead
- Contribution to journal › Article
-
Mark
How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector
- Contribution to journal › Article
-
Mark
Challenges for the sustainability of university-run biobanks
- Contribution to journal › Article
-
Mark
Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
(2018) In Life Sciences Intellectual Property Review (LSIPR)
- Contribution to journal › Article
-
Mark
Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?
(2018) In CEIPI / ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System p.121-130
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Clearing a way through the CRISPR patent jungle
(2018) In Life Sciences Intellectual Property Review (LSIPR)
- Contribution to journal › Article
-
Mark
Reap what you sow! - But what about SPC squatting?
- Contribution to journal › Article
-
Mark
Big Data and intellectual property rights in the health and life sciences
(2018) p.311-323
- Chapter in Book/Report/Conference proceeding › Book chapter